Inflammatory bowel disease (IBD) is a complex and multifaceted disorder of the
gastrointestinal tract that is increasing in incidence worldwide and associated with …

Embolization with microspheres is a therapeutic strategy based on the selective occlusion of
the blood vessels feeding a tumor. This procedure is intraarterially performed in the clinical …

The aim of the present study was to correlate laboratory data and postprocedural
parameters after conventional transarterial chemoembolization (cTACE) for hepatocellular …

Hepatocellular carcinoma (HCC) is one of the most lethal tumors in China and worldwide,
although first-line therapies for HCC, such as atezolizumab and bevacizumab, have been …

Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver malignancy
and is increasing in incidence. Long-term outcomes are optimized when patients undergo …

Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver and has an
overall five-year survival rate of less than twenty percent. For patients with unresectable …

Simple Summary The role of imaging in the management of hepatocellular carcinoma
(HCC) has significantly evolved and expanded beyond the plain radiological confirmation of …

The safety and efficacy of 166Ho radioembolization was first determined in the HEPAR and
HEPAR II studies, which, however, excluded patients with hepatocellular carcinoma (HCC) …

Simple Summary The survival of patients with hepatocellular carcinoma (HCC) is highly
variables, due to heterogeneous tumor burden and liver dysfunction. Tumor burden score …

Simple Summary Liver transplantation (LT) is an important therapeutic option in selected
patients with hepatocellular carcinoma (HCC). Tumor factors such as size and number of …